Phase III Randomized Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) Versus 5-Fluorouracil (5-FU) in Pancreatic Cancer Patients That Have Progressive Disease Following Gemcitabine HCl Treatment.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 02 Dec 2011
At a glance
- Drugs Fluorouracil; Rubitecan
- Indications Pancreatic cancer
- Focus Registrational; Therapeutic Use
- 04 Sep 2005 New trial record.